{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05718791",
            "orgStudyIdInfo": {
                "id": "hhf"
            },
            "organization": {
                "fullName": "Henry Ford Health System",
                "class": "OTHER"
            },
            "briefTitle": "CXCL9 and EASIX for Prediction of Acute Graft Versus Host Disease",
            "officialTitle": "CXC-chemokine Ligand 9 (CXCL9) and Endothelial Activation and Stress Index (EASIX) for Prediction of Acute Graft Versus Host Disease",
            "therapeuticArea": [
                "Other"
            ],
            "study": "and-easix-for-prediction-of-acute-graft-versus-host-disease"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-05-10",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-03-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-03-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-01-30",
            "studyFirstSubmitQcDate": "2023-01-30",
            "studyFirstPostDateStruct": {
                "date": "2023-02-08",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-04-22",
            "lastUpdatePostDateStruct": {
                "date": "2024-04-23",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Shatha Farhan",
                "investigatorTitle": "Clinical Assistant Professor",
                "investigatorAffiliation": "Henry Ford Health System"
            },
            "leadSponsor": {
                "name": "Henry Ford Health System",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The prediction of severe acute GVHD before it occurs is of high importance for ensuing clinical decisions and overall success of allogeneic SCT. The key immunologic signatures associated with clinical outcomes after different graft versus host disease prophylaxis methods or peripheral blood stem cell transplant are largely unknown."
        },
        "conditionsModule": {
            "conditions": [
                "GVHD,Acute"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "enrollmentInfo": {
                "count": 100,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "interventions": [
                {
                    "type": "DIAGNOSTIC_TEST",
                    "name": "blood sample",
                    "description": "blood sample to check CXCL9 and EASIX at day 28 post stem cell transplant"
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "predictors of acute GVHD",
                    "description": "CXCL9 combined with EASIX can be used as predictors of acute GVHD",
                    "timeFrame": "CXCL9 combined with EASIX calculated at day 28 +/- 2 post SCT can be used as predictors of acute GVHD by day 100."
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients \\>18 year old admitted for allo SCT PB for malignant disease.",
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "80 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "Patients \\>18 year old admitted for allo SCT PB for malignant disease",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "shatha farhan, MD",
                    "role": "CONTACT",
                    "phone": "3137133910",
                    "email": "sfarhan1@hfhs.org"
                }
            ],
            "locations": [
                {
                    "facility": "Henry Ford Health System",
                    "status": "RECRUITING",
                    "city": "Detroit",
                    "state": "Michigan",
                    "zip": "48202",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "shatha farhan",
                            "role": "CONTACT",
                            "phone": "313-916-5002",
                            "email": "sfarhan1@hfhs.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.33143,
                        "lon": -83.04575
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000006086",
                    "term": "Graft vs Host Disease"
                }
            ],
            "ancestors": [
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9189",
                    "name": "Graft vs Host Disease",
                    "asFound": "Graft Versus Host Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T170",
                    "name": "Acute Graft Versus Host Disease",
                    "asFound": "Acute Graft Versus Host Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "T2832",
                    "name": "Homologous Wasting Disease",
                    "asFound": "Graft Versus Host Disease",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}